Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Up 136.

3 days ago · Aadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 547,500 …

0%
OFF

Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Up 136.0% In ...

1 week from now

1 day ago · Aadi Bioscience Stock Up 8.4 %. AADI stock opened at $3.24 on Thursday. The stock has a market cap of $79.86 million, a PE ratio of -1.42 and a beta of 0.65. The firm’s 50-day …

etfdailynews.com

8%
OFF

Aadi Bioscience, Inc. (NASDAQ:AADI) Sees Significant Decline In …

1 week from now

Dec 2, 2024 · As of November 15th, there was short interest totalling 256,500 shares, a decrease of 8.8% from the October 31st total of 281,100 shares. ... Aadi Bioscience, Inc. …

etfdailynews.com

27%
OFF

Aadi Bioscience (NASDAQ:AADI) Stock, Short Interest Report

1 week from now

Short interest in Aadi Bioscience Inc (NASDAQ:AADI) increased during the last reporting period, rising from 231.97K to 547.54K. This put 3.27% of the company's publicly available shares short.

benzinga.com

1%
OFF

Aadi Bioscience (NASDAQ:AADI) Shares Down 16.1% - What's …

1 week from now

3 days ago · Aadi Bioscience Price Performance. The firm has a market cap of $74.43 million, a PE ratio of -1.32 and a beta of 0.65. The business has a 50-day simple moving average of …

marketbeat.com

FAQs about Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Up 136. Coupon?

How much does Aadi Bioscience stock cost?

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Aadi Bioscience is $1.67, with a high forecast of $1.75 and a low forecast of $1.50. Should I buy or sell Aadi Bioscience stock right now? ...

Does Aadi Bioscience have a downside?

According to analysts, Aadi Bioscience's stock has a predicted downside of -48.08% based on their 12-month stock forecasts. Do Wall Street analysts like Aadi Bioscience more than its competitors? Analysts like Aadi Bioscience less than other "medical" companies. ...

Who owns Aadi Bioscience?

Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Aadi Bioscience during the second quarter valued at about $37,000. Finally, BML Capital Management LLC acquired a new stake in Aadi Bioscience in the third quarter worth about $4,120,000. 52.08% of the stock is currently owned by institutional investors and hedge funds. ...

Should you buy Aadi Bioscience (Aadi)?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aadi Bioscience in the last twelve months. There are currently 5 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AADI shares. ...

How did Aadi Bioscience (Aadi) perform in a quarter?

Aadi Bioscience (NASDAQ:AADI – Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported ($0.46) EPS for the quarter, meeting the consensus estimate of ($0.46). The company had revenue of $7.21 million for the quarter, compared to analyst estimates of $6.55 million. ...

Where is Aadi BioScience headquartered?

Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California. Read More… Aadi Bioscience Stock Analysis - MarketRank™ Aadi Bioscience scored higher than 26% of companies evaluated by MarketBeat, and ranked 826th out of 945 stocks in the medical sector. ...